Archive


Category: ~427M

  • Pacira to Acquire Flexion for ~427M

    Shots: Pacira Signs a definitive agreement to acquire Flexion for $8.50/share in cash along with one non-tradeable CVR of ~$8.00/share in cash upon the achievement of sales & regulatory milestones. The transaction is expected to close in Q4’21 The acquisition will support Pacira to expand its leadership position in non-opioid pain management with the addition […]